Cargando…

Fatty acid binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway

Fatty acid binding protein 1 (FABP1) is an intracellular protein responsible for transportation of long chain fatty acids. Aside from its functions in lipid metabolism and cellular differentiation, FABP1 also plays a role in inflammation through its interaction with peroxisome proliferator activated...

Descripción completa

Detalles Bibliográficos
Autores principales: Wood, Stephanie M, Gill, Anthony J, Brodsky, Alexander S, Lu, Shaolei, Friedman, Kenneth, Karashchuk, Galina, Lombardo, Kara, Yang, Dongfang, Resnick, Murray B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5218856/
https://www.ncbi.nlm.nih.gov/pubmed/27687006
http://dx.doi.org/10.1038/modpathol.2016.170
_version_ 1782492355750789120
author Wood, Stephanie M
Gill, Anthony J
Brodsky, Alexander S
Lu, Shaolei
Friedman, Kenneth
Karashchuk, Galina
Lombardo, Kara
Yang, Dongfang
Resnick, Murray B
author_facet Wood, Stephanie M
Gill, Anthony J
Brodsky, Alexander S
Lu, Shaolei
Friedman, Kenneth
Karashchuk, Galina
Lombardo, Kara
Yang, Dongfang
Resnick, Murray B
author_sort Wood, Stephanie M
collection PubMed
description Fatty acid binding protein 1 (FABP1) is an intracellular protein responsible for transportation of long chain fatty acids. Aside from its functions in lipid metabolism and cellular differentiation, FABP1 also plays a role in inflammation through its interaction with peroxisome proliferator activated receptors. Previously, we compared expression of colonic epithelium genes in a subset of microsatellite instable (MSI) colorectal carcinomas (medullary carcinomas) to normal colonic mucosa and found that FABP1 expression was markedly decreased in the tumors. Further analysis of RNA expression in the colorectal subtypes and The Cancer Genome Atlas dataset found that FABP1 expression is decreased in the CMS1 subset of colorectal carcinomas, which is characterized by microsatellite instability. As microsatellite instable colorectal carcinomas are known for their robust immune response, we then aimed to link FABP1 to the immune microenvironment of microsatellite instable carcinomas. To confirm the gene expression results, we performed immunohistochemical analysis of a cohort of colorectal carcinomas. FABP1 was preferentially lost in microsatellite instable carcinomas (123/133, 93%) compared to microsatellite stable carcinomas (240/562, 43%, p <0.0001). In addition, higher numbers of tumor infiltrating lymphocytes were present in tumors with loss of FABP1 (p<0.0001). Decreased expression of the fatty acid storage and glucose regulator, peroxisome proliferator activated receptor γ (PPARγ), was associated with loss of FABP1 (p<0.0001). Colorectal cancer cell lines treated with interferon γ exhibited decreased expression of FABP1. FABP1 expression was partially recovered with treatment of the cell lines with rosiglitazone, a PPARγ agonist. This study demonstrated that loss of FABP1 expression is associated with microsatellite instable carcinomas and that interferon γ stimulation plays a role in this process via its interaction with PPARγ.
format Online
Article
Text
id pubmed-5218856
institution National Center for Biotechnology Information
language English
publishDate 2016
record_format MEDLINE/PubMed
spelling pubmed-52188562017-03-30 Fatty acid binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway Wood, Stephanie M Gill, Anthony J Brodsky, Alexander S Lu, Shaolei Friedman, Kenneth Karashchuk, Galina Lombardo, Kara Yang, Dongfang Resnick, Murray B Mod Pathol Article Fatty acid binding protein 1 (FABP1) is an intracellular protein responsible for transportation of long chain fatty acids. Aside from its functions in lipid metabolism and cellular differentiation, FABP1 also plays a role in inflammation through its interaction with peroxisome proliferator activated receptors. Previously, we compared expression of colonic epithelium genes in a subset of microsatellite instable (MSI) colorectal carcinomas (medullary carcinomas) to normal colonic mucosa and found that FABP1 expression was markedly decreased in the tumors. Further analysis of RNA expression in the colorectal subtypes and The Cancer Genome Atlas dataset found that FABP1 expression is decreased in the CMS1 subset of colorectal carcinomas, which is characterized by microsatellite instability. As microsatellite instable colorectal carcinomas are known for their robust immune response, we then aimed to link FABP1 to the immune microenvironment of microsatellite instable carcinomas. To confirm the gene expression results, we performed immunohistochemical analysis of a cohort of colorectal carcinomas. FABP1 was preferentially lost in microsatellite instable carcinomas (123/133, 93%) compared to microsatellite stable carcinomas (240/562, 43%, p <0.0001). In addition, higher numbers of tumor infiltrating lymphocytes were present in tumors with loss of FABP1 (p<0.0001). Decreased expression of the fatty acid storage and glucose regulator, peroxisome proliferator activated receptor γ (PPARγ), was associated with loss of FABP1 (p<0.0001). Colorectal cancer cell lines treated with interferon γ exhibited decreased expression of FABP1. FABP1 expression was partially recovered with treatment of the cell lines with rosiglitazone, a PPARγ agonist. This study demonstrated that loss of FABP1 expression is associated with microsatellite instable carcinomas and that interferon γ stimulation plays a role in this process via its interaction with PPARγ. 2016-09-30 2017-01 /pmc/articles/PMC5218856/ /pubmed/27687006 http://dx.doi.org/10.1038/modpathol.2016.170 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Wood, Stephanie M
Gill, Anthony J
Brodsky, Alexander S
Lu, Shaolei
Friedman, Kenneth
Karashchuk, Galina
Lombardo, Kara
Yang, Dongfang
Resnick, Murray B
Fatty acid binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway
title Fatty acid binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway
title_full Fatty acid binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway
title_fullStr Fatty acid binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway
title_full_unstemmed Fatty acid binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway
title_short Fatty acid binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway
title_sort fatty acid binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5218856/
https://www.ncbi.nlm.nih.gov/pubmed/27687006
http://dx.doi.org/10.1038/modpathol.2016.170
work_keys_str_mv AT woodstephaniem fattyacidbindingprotein1ispreferentiallylostinmicrosatelliteinstablecolorectalcarcinomasandisimmunemodulatedviatheinterferongpathway
AT gillanthonyj fattyacidbindingprotein1ispreferentiallylostinmicrosatelliteinstablecolorectalcarcinomasandisimmunemodulatedviatheinterferongpathway
AT brodskyalexanders fattyacidbindingprotein1ispreferentiallylostinmicrosatelliteinstablecolorectalcarcinomasandisimmunemodulatedviatheinterferongpathway
AT lushaolei fattyacidbindingprotein1ispreferentiallylostinmicrosatelliteinstablecolorectalcarcinomasandisimmunemodulatedviatheinterferongpathway
AT friedmankenneth fattyacidbindingprotein1ispreferentiallylostinmicrosatelliteinstablecolorectalcarcinomasandisimmunemodulatedviatheinterferongpathway
AT karashchukgalina fattyacidbindingprotein1ispreferentiallylostinmicrosatelliteinstablecolorectalcarcinomasandisimmunemodulatedviatheinterferongpathway
AT lombardokara fattyacidbindingprotein1ispreferentiallylostinmicrosatelliteinstablecolorectalcarcinomasandisimmunemodulatedviatheinterferongpathway
AT yangdongfang fattyacidbindingprotein1ispreferentiallylostinmicrosatelliteinstablecolorectalcarcinomasandisimmunemodulatedviatheinterferongpathway
AT resnickmurrayb fattyacidbindingprotein1ispreferentiallylostinmicrosatelliteinstablecolorectalcarcinomasandisimmunemodulatedviatheinterferongpathway